Using our “global reach with a local touch” model to win share and new business 3. All Rights Reserved 2025 9 Regional manufacturing capabilities and supply chains help us serve our customers locally Global reach with a local touch Sales exposure $100M ~3%LESSTHAN Raw materials exposure $100M ~7.5%LESSTHAN Tariff exposure 2025 guidance Copyright © . All Rights Reserved 2025 20 Reconciliation of Non-GAAP financial measures Reconciliation to condensed consolidated statements of income Three months ended March 31, 2023 $ Millions EPS (in $) Net income from continuing operations attributable to Avient common shareholders 20.8 0.23 Special items, after-tax 22.3 0.24 Amortization expense, after-tax 15.1 0.16 Adjusted net income / EPS 58.2 0.63 1 Reconciliation to EBITDA and Adjusted EBITDA Year ended December 31, 2024 $ Millions Net income – GAAP 170.7 Income tax expense 54.1 Interest expense 105.6 Depreciation & amortization 179.7 EBITDA 510.1 Special items, before tax 20.1 Interest expense included in special items (2.3) Depreciation & amortization included in special items (1.5) Adjusted EBITDA 526.4 Adjusted EBITDA as a percent of sales 16.2% PAGE 3 OF 3 Reconciliation to condensed consolidated statements of income Three months ended June 30, 2024 $ Millions EPS (in $) Net income attributable to Avient common shareholders 33.6 0.36 Special items, after-tax 21.8 0.24 Amortization expense, after-tax 14.8 0.16 Adjusted net income / EPS 70.2 0.76 Reconciliation to condensed consolidated statements of income Year ended December 31, 2024 $ Millions EPS (in $) Net (loss) income attributable to Avient common shareholders 169.5 1.84 Special items, after-tax 15.9 0.17 Amortization expense, after-tax 59.5 0.65 Adjusted net income / EPS 244.9 2.66 Per share amounts may not recalculate from figures present herein due to rounding 1 1 1 Q1 2025 Earnings webcast Slide 1 Slide 2: Disclaimer Slide 3: Q1 2025 highlights Slide 4: Q1 2025 organic revenue growth - by region Slide 5: Playbook in current environment Slide 6 Slide 7: Color, Additives & Inks – Q1 2025 performance Slide 8: Specialty Engineered Materials – Q1 2025 performance Slide 9: Global reach with a local touch Slide 10 Slide 11: 2025 financial guidance unchanged...

Any onward transfer is subject to compliance by the data importer with all the other safeguards under these Clauses, in particular purpose limitation. 8.9 Documentation and compliance a. The Parties shall be able to demonstrate compliance with these Clauses. The Parties shall be able to demonstrate compliance with these Clauses.

H Y P O D E R M I C N E E D L E M A N U FAC T U R E R N E E D L E H U B , C O V E R A N D S H I E L D • Compliance to ISO 6009 color coding for single use hypodermic needle • Biocompatibility of all component materials • Good mechanical and visual properties after sterilization (e.g. AVIENT SOLUTION COMPLIANCE + QUALITY LEARN MORECopyright © 2021, Avient Corporation.

E L E C T R I C A L PA RT S M A N U FAC T U R E R H E A V Y D U T Y C O N N E C T O R S A N D A C C E S S O R I E S • Reduce material rematching and rejection through more efficient pre-testing • Improve processing efficiencies and color consistency in highly FR-filled and high-temperature resins • Achieve regulatory compliance across multiple resin families • Gain better supply chain control to manage scarcity of key engineering resins and changing resin producers • Offered eight UL 94-recognized sites in U.S. and Canada that perform comprehensive analytical, physical and mechanical testing • Provided increased speed to market and expedited design timelines for new products using existing standardized and pre- approved color palettes • Ensured regulatory compliance and security of supply OnColor™ UL 94 Colorants KEY REQUIREMENTS WHY AVIENT AVIENT SOLUTION QUALITY + SPEED TO MARKET LEARN MORE © 2023, Avient Corporation, All Rights Reserved https://www.avient.com/products/polymer-colorants/solid-color-masterbatches/oncolor-ul94-colorants

H O M E W A R E P RO D U C T S M A N U FAC T U R E R C L I P & L O C K C L O S U R E • Food contact compliance • Good compatibility • Excellent hinging properties • Reduce strain marks • Retain clarity • Provided extensive technical support throughout formulation development • Met exact mechanical properties, provided excellent hinging properties and reduced strain whitening marks • Increased flexibility & lowered temperature flexing properties • Enabled customer to differentiate products & add value for the end consumer Versaflex™ Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT? AVIENT SOLUTION FOOD COMPLIANCE + PERFORMANCE LEARN MORE Copyright © 2020, Avient Corporation.

F O O D P RO C E S S I N G B E LT M A N U FAC T U R E R C O N V E Y O R B E L T • Electrical resistivity of E+8 Ω • FDA and EU 10/2011 food compliant • Designed to meet ATEX standard • Light color (white) • Provided a permanent statically dissipative solution • Met stringent compliance requirements • Reduced manufacturing steps from two-step process to single-step process Stat-Tech™ Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT? AVIENT SOLUTION UNIQUE ATEX + FDA COMPLIANCE LEARN MORE Copyright © 2023, Avient Corporation.

Formulated with pre-tested raw materials, this range of additives helps enhance the performance and functionality of plastics used in medical devices and pharmaceutical packaging and mitigate the risk of non-compliance.

Compliance with these expectations is regularly evaluated through our comprehensive EH&S audit program.

Flame-retardant formulations, offering UL certification and compliance while maintaining the performance of the base engineering resin

Pre-tested for USP Class VI compliance, they are excellent for use in specialty medical devices, surgical devices, and other vital healthcare applications.